International PatientsNewsContact
HACETTEPE UNIVERSITYHOSPITALS
Appointment
EN
  1. Home
  2. Doctors
  3. Prof. Dr. Sevim Erdem Özdamar
Prof. Dr. Sevim Erdem Özdamar

Prof. Dr.

Sevim Erdem Özdamar

Neurology · Adult Hospital

Neuromuscular disorders.
Appointment

About

Sevim Erdem Özdamar received her MD degree from Hacettepe University School of Medicine, Ankara Turkey. In 1989. She then continued her training as a resident first in Gazi University Department of Neurology then in Hacettepe University Department of Neurology. After completing her residency she continued her training on neuromuscular diseases as a research fellow in Ohio State University Department of Neurology in 1996-1997. She especially worked on interpretation of nevre and muscle biopsies. She took up a position in Hacettepe University Department of Neurology as a university lecturer in 1998. She currently holds a position as a Professor in the same Department and she is stil the head of the department.

Dr. Erdem Özdamar has a long-standing interest in every aspect of neuromuscular disorders especially interested in immune –mediated neuropathies and painful neuropathies. She received Hacettepe University 2003-2004 promoting science award for her studies on neuromuscular diseases. She has co-authored 43 peer-reviewed publications in international journals.

Education

  1. Nöropatik Ağrı
    Algoloji
  2. Nöromusküler Hastalıklar
    Nöroloji
  3. MSc — Nöroloji
    Hacettepe
  4. 1989
    Tıp
    Hacettepe
  5. 1983
    TED Ankara Koleji

Expertise

Neuromuscular disorders.

Publications

Source: Hacettepe University academic database (AVESİS) · All publications (102) ↗

Articles 64

  1. Increased epidermal growth factor expression in amyotrophic lateral sclerosis patients: A potential protective mechanism against pressure ulcersARSLAN D., KURT E., ERGÜL ÜLGER Z., ERDEM ÖZDAMAR S., Tan E., Bekircan-Kurt C. E.Turk Noroloji Dergisi, cilt.32, sa.3, ss.230-236, 2026 (ESCI, Scopus)
  2. Detection of inflammation and glial cell-related biomarkers in adults with spinal muscular atrophy receiving nusinersen therapyArslan D., ERGÜL ÜLGER Z., Goksen S., Inan B., ESENDAĞLI G., ERDEM ÖZDAMAR S., et al.Neurological Sciences, cilt.47, sa.1, 2026 (SCI-Expanded, Scopus)
  3. Random X chromosome inactivation in female Charcot-Marie-Tooth disease type X1: insights from sural nerve biopsy analysisKURT C. E., Aksu-Menges E., Kumtepe E. T., DURMAZ ÖZDİNÇ C. D., Terzi Y. K., ERGÜL ÜLGER Z., et al.BMC NEUROLOGY, cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)
  4. Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia GravisARSLAN D., ERGÜL ÜLGER Z., Goksen S., ESENDAĞLI G., ERDEM ÖZDAMAR S., Tan E., et al.EUROPEAN NEUROLOGY, cilt.87, sa.5-6, ss.223-229, 2024 (SCI-Expanded, Scopus)
  5. Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravisİNAN B., ORHAN İ. G., KURT C. E., ERDEM ÖZDAMAR S., Tan E.IRISH JOURNAL OF MEDICAL SCIENCE, cilt.193, ss.2989-2994, 2024 (SCI-Expanded, Scopus)
  6. Home infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trialsDiaz-Manera J., Hughes D., Erdem-Ozdamar S., Tard C., Behin A., Bouhour F., et al.MOLECULAR GENETICS AND METABOLISM, cilt.143, sa.4, 2024 (SCI-Expanded, Scopus)
  7. A novel pathogenic PTRH2 variant indicates seizure association with protein-truncating variants in Infantile-Onset Multisystem Neurologic, Endocrine and Pancreatic Disease (IMNEPD)AKÇİN Ö. Ç., KURTÇU O., DERİCİOĞLU N., ERDEM ÖZDAMAR S., KURT C. E., ALTINER Ş., et al.EUROPEAN JOURNAL OF HUMAN GENETICS, ss.1494, 2024 (SCI-Expanded, Scopus)
  8. A novel pathogenic PTRH2 variant indicates seizure association with protein-truncating variants in Infantile-Onset Multisystem Neurologic, Endocrine and Pancreatic Disease (IMNEPD)AKÇİN Ö. Ç., KURTÇU O., DERİCİOĞLU N., ERDEM ÖZDAMAR S., KURT C. E., ALTINER Ş., et al.EUROPEAN JOURNAL OF HUMAN GENETICS, ss.1494, 2024 (SCI-Expanded, Scopus)
  9. Differentiating recurrent Guillain-Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature reviewİNAN B., KURT C. E., Demirci M., ERDEM ÖZDAMAR S., Tan E.ACTA NEUROLOGICA BELGICA, cilt.124, ss.1467-1475, 2024 (SCI-Expanded, Scopus)
  10. VARIABLE PHENOTYPE IN FEMALES WITH HETEROZYGOUS GJB1 MUTATIONKURT C. E., ERGÜL ÜLGER Z., TEMUÇİN Ç. M., Kumtepe E. T., BALCI B., Tan E., et al.JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024 (SCI-Expanded, Scopus)
  11. Recurrent simultaneous central nervous system demyelination with possible peripheral demyelination / nodopathy in a seronegative patientİNAN B., KURT C. E., YILDIZ SARIKAYA F. G., GÖÇMEN R., TEMUÇİN Ç. M., Tuncer A., et al.IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, cilt.77, sa.9-10, ss.357-360, 2024 (SCI-Expanded, Scopus)
  12. Nusinersen for adults with spinal muscular atrophyARSLAN D., İNAN B., KILINÇ M., Bekircan-Kurt C. E., ERDEM ÖZDAMAR S., Tan E.Neurological Sciences, cilt.44, sa.7, ss.2393-2400, 2023 (SCI-Expanded, Scopus)
  13. Efficacy and Safety of Avalglucosidase Alfa in Patients with Late-Onset Pompe Disease after 97 Weeks: A Phase 3 Randomized Clinical TrialKishnani P. S., Diaz-Manera J., Toscano A., Clemens P. R., Ladha S., Berger K. I., et al.JAMA Neurology, cilt.80, sa.6, ss.558-567, 2023 (SCI-Expanded, Scopus)
  14. The evaluation of small fibers in multiple sclerosisBekircan-Kurt C. E., Jahanroshan J., Tuncer A., ERGÜL ÜLGER Z., Gunes G., ERDEM ÖZDAMAR S., et al.Multiple Sclerosis and Related Disorders, cilt.72, 2023 (SCI-Expanded, Scopus)
  15. Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspectiveERDEM ÖZDAMAR S., KOÇ A. F., Durmus Tekce H., Kotan D., Ekmekci A. H., ŞENGÜN İ. Ş., et al.Frontiers in Neurology, cilt.14, 2023 (SCI-Expanded, Scopus)
  16. Efficacy and safety of Avalglucosidase Alfa in participants with late-onset Pompe Disease after 145 weeks' treatment during the COMET trialSchoser B., Kishnani P., Kushlaf H., Ladha S., Mozaffar T., Straub V., et al.NEUROMUSCULAR DISORDERS, cilt.32, 2022 (SCI-Expanded, Scopus)
  17. COMET: Efficacy and safety of avalglucosidase alfa in late-onset Pompe disease participants after 97 weeks of treatmentSchoser B., Kishnani P., Diaz-Manera J., Kushlaf H., Ladha S., Mozaffar T., et al.EUROPEAN JOURNAL OF NEUROLOGY, cilt.29, ss.59-60, 2022 (SCI-Expanded, Scopus)
  18. Home-infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trials (COMET, NEO-EXT, and Mini-COMET)Daz-Manera J., Hughes D., Behin A., Bouhour F., Davison J., ERDEM ÖZDAMAR S., et al.MOLECULAR GENETICS AND METABOLISM, cilt.135, sa.2, 2022 (SCI-Expanded, Scopus)
  19. The avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients: Efficacy and safety results after 97 weeksKishnani P., Diaz-Manera J., Kushlaf H., Ladha S., Mozaffar T., Straub V., et al.MOLECULAR GENETICS AND METABOLISM, cilt.135, sa.2, 2022 (SCI-Expanded, Scopus)
  20. Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patientsKishnani P. S., Attarian S., Borges J. L., Bouhourd F., Chien Y., Choi Y., et al.MOLECULAR GENETICS AND METABOLISM, cilt.132, sa.2, 2021 (SCI-Expanded, Scopus)
  21. Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relativesPekgul F., Eroglu-Ertugrul N. G., Bekircan-Kurt C. E., Erdem-Ozdamar S., Cetinkaya A., Tan E., et al.MOLECULAR GENETICS AND METABOLISM REPORTS, cilt.25, 2020 (SCI-Expanded, Scopus)
  22. Laboratory diagnosis of metachromatic leukodystrophy requires more than arylsulfatase A assayPekgul F., Bekircan-Kurt C. E., Konuskan B., Erdem-Ozdamar S., Tan E., Akarsu N., et al.FEBS OPEN BIO, cilt.9, ss.199, 2019 (SCI-Expanded, Scopus)
  23. Novel SBF2 mutations and clinical spectrum of Charcot-Marie-Tooth neuropathy type 4B2Lassuthova P., Vill K., Erdem-Ozdamar S., Schroeder J. M., Topaloglu H., Horvath R., et al.CLINICAL GENETICS, cilt.94, sa.5, ss.467-472, 2018 (SCI-Expanded, Scopus)
  24. Establishment of primary myoblast cell cultures from cryopreserved skeletal muscle biopsies to serve as a tool in related research & development studiesBalci-Hayta B., Bekircan-Kurt C. E., AKSU MENGEŞ E., DAYANGAÇ ERDEN D., Tan E., ERDEM ÖZDAMAR S.JOURNAL OF THE NEUROLOGICAL SCIENCES, cilt.393, ss.100-104, 2018 (SCI-Expanded, Scopus)
  25. Do Perineuronal Net Elements Contribute to Pathophysiology of Spinal Muscular Atrophy? In Vitro and Transcriptomics InsightsDAYANGAÇ ERDEN D., GÜR DEDEOĞLU B., Eskici F. N., Oztemur-Islakoglu Y., ERDEM ÖZDAMAR S.OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, cilt.22, sa.9, ss.598-606, 2018 (SCI-Expanded, Scopus)
  26. The histopathological evaluation of small fiber neuropathy in patients with vitamin B12 deficiencyGunes H. N., Bekircan-Kurt C. E., Tan E., ERDEM ÖZDAMAR S.ACTA NEUROLOGICA BELGICA, cilt.118, sa.3, ss.405-410, 2018 (SCI-Expanded, Scopus)
  27. Ocular surface alterations and in vivo confocal microscopic characteristics of corneas in patients with myasthenia gravisERKAN TURAN K., KOCABEYOĞLU S., Bekircan-Kurt C. E., BEZCİ F., ERDEM ÖZDAMAR S., Irkec M.EUROPEAN JOURNAL OF OPHTHALMOLOGY, cilt.28, sa.5, ss.541-546, 2018 (SCI-Expanded, Scopus)
  28. A rare cause of proximal muscle weakness: immune necrotising myopathyGÜVEN D. C., ERDEN A., KILIÇ L., ERDEM ÖZDAMAR S., KARADAĞ Ö.SCOTTISH MEDICAL JOURNAL, cilt.63, sa.3, ss.82-86, 2018 (SCI-Expanded, Scopus)
  29. A database for screening and registering late onset Pompe disease in TurkeyGokyigit M. C., Ekmekci H., Durmus H., Karll N., KÖSEOĞLU E., Aysal F., et al.NEUROMUSCULAR DISORDERS, cilt.28, sa.3, ss.262-267, 2018 (SCI-Expanded, Scopus)
  30. The altered expression of perineuronal net elements during neural differentiationEskici N. F., ERDEM ÖZDAMAR S., DAYANGAÇ ERDEN D.CELLULAR & MOLECULAR BIOLOGY LETTERS, cilt.23, 2018 (SCI-Expanded, Scopus)
  31. Recent therapeutic developments in spinal muscular atrophyBORA G., YEŞBEK KAYMAZ A., Bekircan Kurt C. E., HALİLOĞLU V. G., TOPALOĞLU H. A., Erdem Yurter H., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.48, sa.2, ss.203-211, 2018 (SCI-Expanded, Scopus, TRDizin)
  32. Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle diseaseInal-Gultekin G., Toptas-Hekimoglu B., Gormez Z., Gelisin O., Durmus H., Erguner B., et al.NEUROMUSCULAR DISORDERS, cilt.27, sa.11, ss.997-1008, 2017 (SCI-Expanded, Scopus)
  33. New mutations and genotype-phenotype correlation in late-onset Pompe patientsBekircan-Kurt C. E., Gunes H. N., Yildiz F. G., SAKA TOPÇUOĞLU E., Tan E., ERDEM ÖZDAMAR S.ACTA NEUROLOGICA BELGICA, cilt.117, sa.1, ss.269-275, 2017 (SCI-Expanded, Scopus)
  34. Transcript levels of plastin 3 and neuritin 1 modifier genes in spinal muscular atrophy siblingsYener I. H., Topaloglu H., ERDEM ÖZDAMAR S., DAYANGAÇ ERDEN D.PEDIATRICS INTERNATIONAL, cilt.59, sa.1, ss.53-56, 2017 (SCI-Expanded, Scopus)
  35. Dysferlinopathy: A Case Report and Literature UpdateKutlu O., KURT C. E., Unsal I., Aribas Z., Renkliyildiz B., Eruzun H., et al.ISTANBUL MEDICAL JOURNAL, cilt.17, sa.4, ss.136-140, 2016 (ESCI, TRDizin)
  36. The evaluation of small fibres in asymptomatic patients with Val30Met mutationBekircan-Kurt C. E., Yildiz F. G., Gunes H. N., Erdem-Ozdamar S., Tan E.EUROPEAN JOURNAL OF NEUROLOGY, cilt.23, ss.231, 2016 (SCI-Expanded, Scopus)
  37. Autoimmune stormAslan S., Bekircan-Kurt C. E., Kurne A. T., Erdem-Ozdamar S.EUROPEAN JOURNAL OF NEUROLOGY, cilt.23, ss.437, 2016 (SCI-Expanded, Scopus)
  38. Spinal muscular atrophy type III: Molecular genetic characterization of Turkish patientsBORA-TATAR G., YESBEK-KAYMAZ A., BEKIRCAN-KURT C. E., ERDEM-OZDAMAR S., Erdem-Yurter H.EUROPEAN JOURNAL OF MEDICAL GENETICS, cilt.58, sa.12, ss.654-658, 2015 (SCI-Expanded, Scopus)
  39. Three Turkish families with different transthyretin mutationsBekirean-Kurt C. E., GUNES N., Yilmaz A., ERDEM-OZDAMAR S., TAN E.NEUROMUSCULAR DISORDERS, cilt.25, sa.9, ss.686-692, 2015 (SCI-Expanded, Scopus)
  40. Proinflammatory effect of AbetaPP induced ST6GAL1 secretion from C2C12 myogenic cell lineHAYTA B., ERDEM ÖZDAMAR S., Dincer P.TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.40, sa.1, ss.31-36, 2015 (SCI-Expanded, Scopus, TRDizin)
  41. Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approachZimon M., BATTALOĞLU E., Parman Y., Erdem S., Baets J., De Vriendt E., et al.NEUROGENETICS, cilt.16, sa.1, ss.33-42, 2015 (SCI-Expanded, Scopus)
  42. REMISSION WITH FINGOLIMOD IN A CASE OF DEMYELINATING POLYNEUROPATHYERDENER Ş. E., NURLU G., GÖÇMEN R., Erdem-Ozdamar S., KURNE A.MUSCLE & NERVE, cilt.50, sa.4, ss.615-617, 2014 (SCI-Expanded, Scopus)
  43. The Course of Myasthenia Gravis with Systemic Lupus ErythematosusBekircan-Kurt C. E., Kurne A. T., Erdem-Ozdamar S., Kalyoncu U., Karabudak R., Tan E.EUROPEAN NEUROLOGY, cilt.72, ss.326-329, 2014 (SCI-Expanded, Scopus)
  44. A novel desmin mutation leading to autosomal recessive limb-girdle muscular dystrophy: distinct histopathological outcomes compared with desminopathiesCetin N., Balci-Hayta B., Gundesli H., KORKUSUZ P., PURALI N., TALİM B., et al.JOURNAL OF MEDICAL GENETICS, cilt.50, sa.7, ss.437-443, 2013 (SCI-Expanded, Scopus)
  45. Myasthenia Gravis; Single Entity, Variable Clinical Features: Ten Years of Clinical Experience in a Tertiary Care Center Ten Years Clinical Experience of a Tertiary Care CenterBEKIRCAN-KURT C. E., KURNE A., ERDEM ÖZDAMAR S., KARABUDAK R., KANSU T., TAN E.JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, cilt.30, sa.1, ss.135-143, 2013 (SCI-Expanded, Scopus, TRDizin)
  46. Identification of a Novel Twinkle Mutation in a Family With Infantile Onset Spinocerebellar Ataxia by Whole Exome SequencingDUNDAR H., ÖZGÜL R. K., YALNIZOĞLU D., Erdem S., Oguz K. K., Tuncel D., et al.PEDIATRIC NEUROLOGY, cilt.46, sa.3, ss.172-177, 2012 (SCI-Expanded, Scopus)
  47. Diabetic muscular infarct: an unusual cause of extremity pain and dysfunctionUcan H., Alemdaroglu E., Yoldas T. K., ERDEM ÖZDAMAR S., Akyuz M., Hatipoglu C.RHEUMATOLOGY INTERNATIONAL, cilt.32, sa.2, ss.525-528, 2012 (SCI-Expanded, Scopus)
  48. Overexpression of amyloid beta precursor protein enhances expression and secretion of ST6Gal1 in C2C12 myogenic cell lineBALCI-HAYTA B., Erdem-Ozdamar S., DINCER P. R.CELL BIOLOGY INTERNATIONAL, cilt.35, sa.1, ss.9-13, 2011 (SCI-Expanded, Scopus)
  49. Early Diagnosis of Distal Peripheral Polyneuropathy Due to Glucose Metabolism Disorders via Intraepidermal Nerve Fiber AnalysisKursun O., KARATAŞ KURŞUN H., ULUÇ K., ERDEM ÖZDAMAR S., Erbas T., Tan E.TURKISH JOURNAL OF NEUROLOGY, cilt.15, sa.1, ss.24-30, 2009 (ESCI, TRDizin)
  50. Nuclear morphometric analysis in gastrointestinal stromal tumors: A preliminary studyÖZDAMAR Ş. O., Bektas S., ERDEM ÖZDAMAR S., Gedikoglu G., DOĞAN GÜN B., BAHADIR B.TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.18, sa.2, ss.71-76, 2007 (SCI-Expanded, Scopus, TRDizin)
  51. Calpain-3 mutations in TurkeyBalci B., Aurino S., Haliloglu G., Talim B., Erdem S., Akcoren Z., et al.EUROPEAN JOURNAL OF PEDIATRICS, cilt.165, sa.5, ss.293-298, 2006 (SCI-Expanded, Scopus)
  52. Giant axonal neuropathy: clinical and genetic study in six casesDEMIR E., BOMONT P., ERDEM S., CAVALIER L., DEMIRCI M., KOSE G., et al.JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, cilt.76, sa.6, ss.825-832, 2005 (SCI-Expanded, Scopus)
  53. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathySenderek J., Bergmann C., Stendel C., Kirfel J., Verpoorten N., De Jonghe P., et al.AMERICAN JOURNAL OF HUMAN GENETICS, cilt.73, sa.5, ss.1106-1119, 2003 (SCI-Expanded, Scopus)
  54. Four novel thymidine phosphorylase gene mutations in mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) patientsKocaefe Y. Ç., Erdem S., Ozguc M., Tan E.EUROPEAN JOURNAL OF HUMAN GENETICS, cilt.11, sa.1, ss.102-104, 2003 (SCI-Expanded, Scopus)
  55. Mutations in GDAP1 - Autosomal recessive CMT with demyelination and axonopathyNelis E., Erdem S., Van den Bergh P., Belpaire-Dethiou M., Ceuterick C., Van Gerwen V., et al.NEUROLOGY, cilt.59, sa.12, ss.1865-1872, 2002 (SCI-Expanded, Scopus)
  56. A novel homozygous missense mutation in the myotubularin-related protein 2 gene associated with recessive Charcot-Marie-Tooth disease with irregularly folded myelin sheathsNelis E., Erdem S., Tan E., Lofgren A., Ceuterick C., De Jonghe P., et al.NEUROMUSCULAR DISORDERS, cilt.12, sa.9, ss.869-873, 2002 (SCI-Expanded, Scopus)
  57. Exercise-induced apoptosis of rat skeletal muscle and the effect of meloxicamArslan S., Erdem S., Sivri A., Hascelik Z., Tan E.RHEUMATOLOGY INTERNATIONAL, cilt.21, sa.4, ss.133-136, 2002 (SCI-Expanded, Scopus)
  58. Cremaster muscle is not sexually dimorphic, but that from boys with undescended testis reflects alterations related to autonomic innervationTanyel F. C., Erdem S., Buyukpamukcu N., Tan E.JOURNAL OF PEDIATRIC SURGERY, cilt.36, sa.6, ss.877-880, 2001 (SCI-Expanded, Scopus)
  59. Cremaster muscles obtained from boys with an undescended testis show significant neurological changesTanyel F. C., Erdem S., Buyukpamukcu N., Tan E.BJU INTERNATIONAL, cilt.85, sa.1, ss.116-119, 2000 (SCI-Expanded, Scopus)
  60. Painful sensory neuropathy: Prospective evaluation using skin biopsyPeriquet M., Novak V., Collins M., Nagaraja H., ERDEM ÖZDAMAR S., Nash S., et al.Neurology, cilt.53, sa.8, ss.1641-1647, 1999 (SCI-Expanded, Scopus)

All 64 on AVESİS →

Conference papers 38

  1. The effect and challenges of nusinersen treatment in adult spinal muscular atrophy patients - preliminary resultsInan B., Bekircan-Kurt C. E., Kilinc M., Erdem-Ozdamar S., Tan E.6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 - 26 Mayıs 2020, cilt.27, ss.625, (Özet Bildiri)
  2. Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP): A Database AnalysisERDOĞAN Ç., Bayrak A. O., ULUÇ K., Karli N., KOÇ A. F., ÖZTÜRK Ş., et al.Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri)
  3. Multimodal Assessment Of Intensive Care Unit-Acquired Weakness (ICU-AW) In Severe Acute Stroke PatientsİNAN B., KURT C. E., TEMUÇİN Ç. M., ARSAVA E. M., TOPÇUOĞLU M. A., ERDEM ÖZDAMAR S., et al.2019 PNS Meeting, 22 - 26 Haziran 2019, (Özet Bildiri)
  4. Nusinersen İlacı İçin Başvuruda Bulunan Spinal Musküler Atrofi Tip 2 ve Tip 3 Tanılı Hastaların ProfiliONURSAL KILINÇ Ö., AYVAT F., SÜTÇÜ G., DOĞAN M., AYVAT E., KILINÇ M., et al.TND II. Nöromusküler Hastalıklar Kongresi, İzmir, Türkiye, 19 - 21 Nisan 2019, (Özet Bildiri)
  5. Erişkin Nöromusküler Hastalarda Düşme Öyküsünün AktiviteLimitasyonu ve Gövde Bozukluk Düzeyi ile İlişkisinin İncelenmesiDOĞAN M., ONURSAL KILINÇ Ö., AYVAT F., SÜTÇÜ G., AYVAT E., KILINÇ M., et al.TND II. Nöromusküler Hastalıklar Kongresi, İzmir, Türkiye, 19 - 21 Nisan 2019, (Özet Bildiri)
  6. Kas Hastalarında Farklı Yüksekliklerden Oturmadan Ayağa Kalkma Sırasında Uyluk Kaslarının Aktivasyon Seviyelerinin İncelenmesiSÜTÇÜ G., DOĞAN M., ONURSAL KILINÇ Ö., AYVAT F., AYVAT E., AKSU YILDIRIM S., et al.TND II. Nöromusküler Hastalıklar Kongresi, İzmir, Türkiye, 19 - 21 Nisan 2019, (Özet Bildiri)
  7. Erişkin Kas Hastalarında Fiziksel Aktiviteyi Objektif ve Subjektif Olarak Değerlendiren Yöntemlerin KarşılaştırılmasıAYVAT F., AYVAT E., ONURSAL KILINÇ Ö., SÜTÇÜ G., DOĞAN M., KILINÇ M., et al.TND II. Nöromusküler Hastalıklar Kongresi, İzmir, Türkiye, 19 - 21 Nisan 2019, (Özet Bildiri)
  8. Erişkin Kas Hastalarında Fiziksel Aktivite ile İlişkili Faktörlerin BelirlenmesiAYVAT F., AYVAT E., ONURSAL KILINÇ Ö., SÜTÇÜ G., DOĞAN M., KILINÇ M., et al.TND II. Nöromusküler Hastalıklar Kongresi, İzmir, Türkiye, 19 - 21 Nisan 2019, (Özet Bildiri)
  9. Nöroloji Yoğun Bakım Ünitesi'ndeki İnme Hastalarında Yoğun Bakım Ünitesinde Edinilmiş Güçsüzlüğün (YBÜ-EG) Multimodal İncelemesiİNAN B., KURT C. E., ERDEM ÖZDAMAR S., ARSAVA E. M., TOPÇUOĞLU M. A., TAN M. E., et al.35. ULUSAL KLİNİK NÖROFİZYOLOJİ EEG-EMG KONGRESİ, Muğla, Türkiye, 3 - 07 Nisan 2019, (Özet Bildiri)
  10. Differentially Expressed microRNA Profile in Skeletal Muscle Tissue of Sporadic ALS PatientsBekircan-Kurt C. E., AKSU MENGEŞ E., Balci-Hayta B., Aydinoglu A. T., Erdem-Ozdamar S., Tan E.71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri)
  11. The expression of epidermal growth factor (EGF) and keratinocyte growth factor (KGF) in skin biopsy of amyotrophic lateral sclerosis patientsKURT E., Bekircan-Kurt C. E., ERDEM ÖZDAMAR S., Tan E.70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)
  12. Altered Expression of Perineuronal Net Elements in SMN Knockdown CellsDayangac-Erden D., Eskici N., Erdem-Ozdamar S.50th European-Society-of-Human-Genetics (ESHG) Conference, Copenhagen, Danimarka, 27 - 30 Mayıs 2017, cilt.26, ss.622, (Özet Bildiri)
  13. Establishment of primary myoblast cell culture from cryoprotected skeletal muscle biopsiesBalci-Hayta B., Bekircan-Kurt C., Aksu E., Dayangac-Erden D., Tan E., Erdem-Ozdamar S.22nd International Annual Congress of the World-Muscle-Society (WMS), Saint-Lo, Fransa, 3 - 07 Ekim 2017, cilt.27, (Özet Bildiri)
  14. VECTOR-BORNE VIRAL INFECTIONS IN GUILLAIN BARRE SYNDROME PATIENTSOkar S., ERGÜNAY K., Bekircan-Kurt C. E., Erdem-Ozdamar S., Tan E.Peripheral-Nerve-Society Meeting, Sitges, İspanya, 8 - 12 Temmuz 2017, cilt.22, ss.349-350, (Özet Bildiri)
  15. Acute myopathy in patients who are using short term and low dose systemic glucocorticoids: preliminary findingsİLBAY A., DURUSU TANRIÖVER M., Bekircan Kurt C. E., YILDIZ SARIKAYA F. G., ÖZIŞIK L., ERDEM ÖZDAMAR S.16th Congress of Internal Medicine, 31 Ağustos - 02 Eylül 2017, (Özet Bildiri)
  16. Acute myopathy in patients who are using short-term and low-dose systemic glucucorticoids: Preliminary findingsİLBAY A., DURUSU TANRIÖVER M., KURT C. E., YILDIZ SARIKAYA F. G., ÖZIŞIK L., ERDEM ÖZDAMAR S.16th European Congress of Internal Medicine, 31 Ağustos - 02 Eylül 2017, (Özet Bildiri)
  17. Desmin Mutation with an ultra rare and unique phenotype: Genome editing for a patient specific zebrafish modelKayman Kürekçi G., Koyunlar C., Kural Mangıt E., Talim B., Korkusuz P., Erdem Özdamar S., et al.keystone symposia Rare and Undiagnosed Diseases, Massachusetts, Amerika Birleşik Devletleri, 3 - 05 Ağustos 2017, (Özet Bildiri)
  18. Recurrent peripheral and central demyelination in a seronegative patientKURT C. E., YILDIZ SARIKAYA F. G., TEMUÇİN Ç. M., TUNCER M. A., TAN M. E., ERDEM ÖZDAMAR S.peripheral Nerve Society Meeting, 8 Temmuz - 13 Eylül 2017, (Özet Bildiri)
  19. Low levels of SMN cause alterations in microtubule associated protein 1bBORA G., Rademacher S., YEŞBEK KAYMAZ A., Hensel N., KURT C. E., ERDEM ÖZDAMAR S., et al.21th Annual Spinal Muscular Atrophy Researcher Meeting, Orlando, Amerika Birleşik Devletleri, 29 Haziran - 02 Temmuz 2017, (Özet Bildiri)
  20. Modeling of a unique desmin mutaion in zebrafish by using genome editing brings new insights into desmin functionKAYMAN KÜREKÇİ G., Koyunlar C., KURAL MANGIT E., TALİM B., ERGİN B., ÜNSAL İ., et al.European Human Genetics Conference, 27 - 30 Mayıs 2017, (Özet Bildiri)
  21. Modeling of a unique desmin mutation in zebrafish by using genome editing brings new insights into desmin functionKAYMAN KÜREKÇİ G., KOYUNLAR C., KURAL MANGIT E., TALİM B., ERGİN B., ÜNSAL S., et al.ESHG 2017, 27 - 30 Mayıs 2017, (Özet Bildiri)
  22. 11 YILLIK MİYASTENİ GRAVİS OLGUSUNDA YENİ GELİŞEN NÖROMİYOTONİSARAYLI A. A. K., ERDEM ÖZDAMAR S., TEMUÇİN Ç. M.33. Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Türkiye, 12 - 16 Nisan 2017, (Özet Bildiri)
  23. The Histopathological Evaluation of Small Fiber Neuropathy in Patients with Vitamin B12 DeficiencyBekircan-Kurt C. E., Gunes N., DEMİRCİ M., ERDEM ÖZDAMAR S., Tan E.68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri)
  24. Myastenia Gravis de Velofaringeal Fonksiyonun AraştırılmasıBAŞTUĞ A., KULAK KAYIKCI M. E., KUŞCU O., KURT C. E., ERDEM ÖZDAMAR S.4. YUTMA BOZUKLUKLARI KONGRESİ, Türkiye, 19 - 21 Kasım 2015, (Özet Bildiri)
  25. The incidence of Pompe disease in patients with vacuolar myopathy: a pilot study of a tertiary care centerBekircan-Kurt C. E., GUNES H. N., ERDEM-OZDAMAR S., TAN E.1st Congress of the European-Academy-of-Neurology, Berlin, Almanya, 20 - 23 Haziran 2015, cilt.22, ss.623, (Özet Bildiri)
  26. A novel mutation in the HTRA1 gene in a Turkish family with CARASILBekircan-Kurt C. E., KOŞUKCU C., KURNE A. T., TOPÇUOĞLU M. A., ERDEM-OZDAMAR S., GÖÇMEN R., et al.1st Congress of the European-Academy-of-Neurology, Berlin, Almanya, 20 - 23 Haziran 2015, cilt.22, ss.258, (Özet Bildiri)
  27. The time course of pseudo-conduction blocks in a patient with vasculitic neuropathyBekircan-Kurt C. E., KALYONCU U., ERDEM-OZDAMAR S., TEMUÇİN Ç. M.Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)
  28. Three families with hereditary amyloid polyneuropathy with three different mutationsBekircan-Kurt C. E., GUNES N., Yilmaz A., ERDEM-OZDAMAR S., TAN E.Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)
  29. A novel desmin mutation causes autosomal recessive limb girdle muscular dystrophy without features of myofibrillar myopathyCetin N., Balci-Hayta B., Gundesli H., KORKUSUZ P., PURALI N., TALİM B., et al.18th International Congress of the World-Muscle-Society (WMS), California, Amerika Birleşik Devletleri, 1 - 05 Ekim 2013, cilt.23, ss.851-852, (Özet Bildiri)
  30. Inflammatory effect of AbetaPP induced ST6Gal1 secretion from myogenic cell lineBalci-Hayta B., Erdem-Ozdamar S., Dincer P. R.16th International Congress of the World-Muscle-Society, Algarve, Portekiz, 18 - 22 Ekim 2011, cilt.21, ss.746, (Özet Bildiri)
  31. MİYASTENİK KRİZ İLE BAŞVURAN HASTALARDA YARDIMCI FOLİKÜLER T HÜCRE (TFH) VE YARDIMCI T HÜCRE 17 (TH17) İLİŞKİLİ SİTOKİNLERİN TEDAVİ ÖNCESİ VE SONRASI DEĞİŞKENLİĞİARSLAN D., ERGÜL ÜLGER Z., gökşen s., ESENDAĞLI G., ERDEM ÖZDAMAR S., TAN M. E., et al.
  32. NUSİNERSEN TEDAVİSİ ALAN ERİŞKİN SPİNAL MUSKÜLER ATROFİ HASTALARINDA İNFLAMASYON VE GLİAL HÜCRE İLİŞKİLİ BİYOBELİRTEÇLERİN TESPİTİARSLAN D., ERGÜL ÜLGER Z., gökşen s., ESENDAĞLI G., ERDEM ÖZDAMAR S., TAN M. E., et al.
  33. Evaluation of the Role of Glial Factors in the Pathogenesis of Spinal Muscular AtrophyARSLAN D., ERGÜL ÜLGER Z., gökşen s., İNAN B., ESENDAĞLI G., ERDEM ÖZDAMAR S., et al.
  34. Serum Cytokines Levels in Patients with Myasthenia Gravis and Their Changes After TreatmentARSLAN D., ERGÜL ÜLGER Z., gökşen s., ESENDAĞLI G., ERDEM ÖZDAMAR S., TAN M. E., et al.
  35. COVID 19 Pandemisinin Nöromusküler Hastalığa Sahip Erişkin Bireyler Üzerine EtkisiONURSAL KILINÇ Ö., SÜTÇÜ UÇMAK G., DOĞAN M., AYVAT F., AYVAT E., AKSU YILDIRIM S., et al.
  36. MME MUTASYONUNA BAĞLI DEMİYELİNİZAN NÖROPATİDemirel Özbek E., ERGÜL ÜLGER Z., TAN M. E., ERDEM ÖZDAMAR S., KURT C. E.
  37. A novel ARMS-PCR assay for screening MT-TL1 mutations causing mitochondrial cytopathiesKILIÇ H. B., Bekircan Kurt C. E., HALİLOĞLU V. G., ERDEM ÖZDAMAR S., TOPALOĞLU H. A., KOCAEFE Y. Ç.
  38. Inflammatory pan-demyelination syndrome IPANDS of the whole nervous systemVural A., GÜLER E., GÖÇMEN R., TUNCER M. A., KARLI OĞUZ H. K., TEMUÇİN Ç. M., et al.

Contact

Department
Neurology, Adult Hospital
Languages
English

Last updated: